These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23891463)

  • 1. Acquired von Willebrand disease in a child with a ventricular assist device.
    Nubret K; Mauriat P; Roubertie F; James C; Tafer N; Ouattara A
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):e30-2. PubMed ID: 23891463
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquired von Willebrand syndrome in a child following Berlin Heart EXCOR Pediatric Ventricular Assist Device implantation: case report and concise literature review.
    Costello JP; Diab YA; Philippe-Auguste M; Jones MB; Shankar V; Friedman KD; Nath DS
    World J Pediatr Congenit Heart Surg; 2014 Oct; 5(4):592-8. PubMed ID: 25324261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients.
    Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Trummer G; Berchtold-Herz M; Schlensak C; Zieger B
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1328-33; discussion 1233. PubMed ID: 21515067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate recovery of acquired von Willebrand syndrome after left ventricular assist device explantation: implications for heart transplantation.
    Davis ME; Haglund NA; Tricarico NM; Matafonov A; Gailani D; Maltais S
    ASAIO J; 2015; 61(1):e1-4. PubMed ID: 25251586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of acquired von Willebrand disease associated with two types of continuous-flow left ventricular assist devices: HeartMate II and CircuLite Synergy Pocket Micro-pump.
    Goda M; Jacobs S; Rega F; Peerlinck K; Jacquemin M; Droogne W; Vanhaecke J; Van Cleemput J; Van den Bossche K; Meyns B
    J Heart Lung Transplant; 2013 May; 32(5):539-45. PubMed ID: 23570742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device.
    Malehsa D; Meyer AL; Bara C; Strüber M
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1091-3. PubMed ID: 19303790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet dysfunction in outpatients with left ventricular assist devices.
    Steinlechner B; Dworschak M; Birkenberg B; Duris M; Zeidler P; Fischer H; Milosevic L; Wieselthaler G; Wolner E; Quehenberger P; Jilma B
    Ann Thorac Surg; 2009 Jan; 87(1):131-7. PubMed ID: 19101285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide for recurrent intestinal bleeding due to ventricular assist device.
    Coutance G; Saplacan V; Belin A; Repessé Y; Buklas D; Massetti M
    Asian Cardiovasc Thorac Ann; 2014 Mar; 22(3):350-2. PubMed ID: 24585917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired von Willebrand Syndrome: An Under-Recognized Cause of Major Bleeding in the Cardiac Intensive Care Unit.
    Jones MB; Ramakrishnan K; Alfares FA; Endicott KM; Oldenburg G; Berger JT; Shankar V; Nath DS; Diab YA
    World J Pediatr Congenit Heart Surg; 2016 Nov; 7(6):711-716. PubMed ID: 27834763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart.
    Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Benk C; Berchtold-Herz M; Trummer G; Schlensak C; Zieger B
    Thromb Haemost; 2010 May; 103(5):962-7. PubMed ID: 20352153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.
    Uriel N; Pak SW; Jorde UP; Jude B; Susen S; Vincentelli A; Ennezat PV; Cappleman S; Naka Y; Mancini D
    J Am Coll Cardiol; 2010 Oct; 56(15):1207-13. PubMed ID: 20598466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of acquired von Willebrand syndrome during short-term micro axial pump support: implications for bleeding in a patient bridged to a long-term continuous-flow left ventricular assist device.
    Davis ME; Haglund NA; Tricarico NM; Keebler ME; Maltais S
    ASAIO J; 2014; 60(3):355-7. PubMed ID: 24614358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
    Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand factor disruption and continuous-flow circulatory devices.
    Proudfoot AG; Davidson SJ; Strueber M
    J Heart Lung Transplant; 2017 Nov; 36(11):1155-1163. PubMed ID: 28756118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.
    Bartoli CR; Restle DJ; Zhang DM; Acker MA; Atluri P
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):281-9. PubMed ID: 25439775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative onset of acquired von Willebrand syndrome: Comparison between HVAD, HeartMate II and on-pump coronary bypass surgery.
    Feldmann C; Zayat R; Goetzenich A; Aljalloud A; Woelke E; Maas J; Tewarie L; Schmitz-Rode T; Autschbach R; Steinseifer U; Moza A
    PLoS One; 2017; 12(2):e0171029. PubMed ID: 28234916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand factor, a versatile player in gastrointestinal bleeding in left ventricular assist device recipients?
    Fischer Q; Huisse MG; Voiriot G; Caron C; Lepage L; Dilly MP; Nataf P; Ajzenberg N; Kirsch M
    Transfusion; 2015 Jan; 55(1):51-4. PubMed ID: 25052086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intractable bleeding tendency due to acquired von Willebrand syndrome after Jarvik 2000 implant.
    Sakatsume K; Akiyama M; Saito K; Kawamoto S; Horiuchi H; Saiki Y
    J Artif Organs; 2016 Sep; 19(3):289-92. PubMed ID: 27021290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
    Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
    J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benchtop von Willebrand Factor Testing: Comparison of Commercially Available Ventricular Assist Devices and Evaluation of Variables for a Standardized Test Method.
    Coghill PA; Kanchi S; Azartash-Namin ZJ; Long JW; Snyder TA
    ASAIO J; 2019 Jul; 65(5):481-488. PubMed ID: 30004942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.